| Product NDC: | 42806-039 |
| Proprietary Name: | Betaxolol |
| Non Proprietary Name: | Betaxolol |
| Active Ingredient(s): | 20 mg/1 & nbsp; Betaxolol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 42806-039 |
| Labeler Name: | Epic Pharma LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075541 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100720 |
| Package NDC: | 42806-039-01 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (42806-039-01) |
| NDC Code | 42806-039-01 |
| Proprietary Name | Betaxolol |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (42806-039-01) |
| Product NDC | 42806-039 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Betaxolol |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20100720 |
| Marketing Category Name | ANDA |
| Labeler Name | Epic Pharma LLC |
| Substance Name | BETAXOLOL HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |